The biotechnology firm BrainChild Bio has raised $116 million in series A funding. The company, which launched in 2023 with seed funding from Seattle Children’s Hospital, wants ...
As artificial intelligence drives breakthroughs in chemistry, the intellectual property community is struggling to keep pace ...
US policymakers have proposed reforms in an attempt to replicate Australia’s success in facilitating speedy Phase 1 clinical ...
Tweaking electronic properties of starting materials can help bypass an obstacle to elusive bicyclic drug scaffold ...
The methods predict the lung irritant risk of surfactants and oral toxicity of some pesticides but shouldn’t completely ...
Visit the C&EN website to play our latest quiz: cenm.ag/september-4-quiz. Concerns about which hazardous compound closed a ...
Dual-use concerns are always worth considering, but we’re more excited than worried about the sciences behind AI-generated ...
First-time disclosures session at ACS Fall 2026 debuted compounds designed to treat cancer, acne, urinary tract infections, and more ...
Readers weigh in on petrochemicals in China, how to improve recycling, the commercialization of universities, and more ...
Acetyl CoA carboxylase inhibitors have been investigated for treating acne and liver disease, but the discarded candidates ...
The atmosphere is “a beaker for chemical reactions,” and “aerosols and droplets are chemical reactors,” says Eric Vejerano, ...
From reducing administrative workload to navigating ‘alien intelligence,’ this month’s column takes a practical look at ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results